New

Asia Pacific Virology Market

2021

Asia Pacific Virology Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Diagnostic Test, Viral Infection Controlling Techniques, Antiviral Therapeutics, and Interferons), Application (Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Sexually Transmitted Diseases, Urinary Tract Infection, and Others), and End User (Hospitals, Diagnostic Laboratories, Pharmaceutical and Biotechnological Companies, and Research and Academic Institutes)

Publication Month: Nov 2021 | Report Code: TIPRE00025735 | No. of Pages: 199 | Category: Biotechnology | Status: Published

Market Insights

Asia Pacific Virology Market to Grow at a CAGR of 4.1% to reach US$ 1,234.44 million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The virology market in APAC is expected to grow from US$ 931.92 million in 2021 to US$ 1,234.44 million by 2028; it is estimated to grow at a CAGR of 4.1% from 2021 to 2028.

China, Japan, India, South Korea, and Australia are major economies in APAC. Countries in Asia Pacific is attractive outsourcing locations for the pharmaceutical and biopharmaceutical industries across the world. Low manufacturing and operating costs and recent growth in the pharmaceutical industry in China and India are key factors driving the growth of the virology-related markets in these countries. Moreover, the growing domestic market and its pipelines are opening new access for the manufacturing of generic drugs in Asia Pacific. In addition, several contract-based organizations are expanding their manufacturing capacities in developing nations to meet the rising demand for products, such as vaccines. Thus, the emerging markets are likely to create lucrative opportunities for the growth of the APAC virology market in the coming years.

COVID-19 has created an unprecedented public health emergency globally. It has demonstrated, emerging infectious diseases represent an existential threat worldwide. Rapid urbanization, deforestation, intensive agriculture, livestock rearing practices, and globalization are increasing opportunities for animal-to-human contacts and epidemics in the region. Urbanization is creating greater potential for epidemics and pandemics, as a large population now lives in cities. In addition, many countries were able to contain the COVID-19 based on previous epidemics. For instance, the South Korean central government began investing in domestic R&D of diagnostic reagents necessary for infectious disease testing. From 2017, it has invested approximately US$ 25 million in infectious disease diagnosis technology. The testing technologies developed by commercial manufacturers through government investments in R&D, including artificial intelligence (AI), proved critical for the government’s rapid launch of an effective COVID-19 response strategy. However, The COVID-19 pandemic has had a major impact on the essential HIV health services in the South East Asia Region, putting the growth at risk over the last two decades. COVID-19 has disrupted essential services causing considerable delays in the delivery of medicines and other health commodities. Changing priorities for HIV clinics and healthcare workers, travel restrictions, non-availability of public and limited private transportation, and worsening socio-economic contexts affected the continuity of essential HIV services. In the Philippines, more than 70% of delays or reductions in the number of visits to HIV clinics have been recorded since the pandemic, according to a survey conducted by Gilead Sciences. HIV and AIDS represented the most recent global pandemic, and the Global Fund has made enormous progress over the past 20 years. According to the study, over 82% of prescribers in India reported a decrease or delay of visits of people living with HIV. COVID-19 has also negatively impacted the uptake of HIV tests, and around 46% of the at-risk population reported a decrease in taking HIV tests during COVID-19. The main reasons for reduced testing were exposure to COVID-19 (62%) and travel restrictions (46%), as HIV tests were mostly only accessible at point-of-care. Therefore, it has negatively affected HIV care and other virus infections.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive virology market. The APAC virology market is expected to grow at a good CAGR during the forecast period.

APAC virology market

Get more information on this report :


APAC Virology Market Segmentation

APAC Virology Market – By Type

  • Diagnostic Test
    • DNA Virus Testing
    • RNA Virus Testing
    • Others
  • Viral Infection Controlling Techniques
    • Active Prophylaxis
    • Passive Prophylaxis
  • Antiviral Therapeutics
    • Virucidal Agents
    • Antiviral Agents
    • Immunomodulators
  • Interferons

APAC Virology Market – By Application

  • Skin and Soft Tissue Infections
  • Respiratory Tract Infections
  • GI Tract Infections
  • Sexually Transmitted Diseases
  • Urinary Tract Infections
  • Others

APAC Virology Market – By End User

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical and Biotechnological Companies
  • Research and Academic Institutes

APAC Virology Market- By Country

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

APAC Virology Market-Companies Mentioned

  • Abbott
  • AbbVie Inc.
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline Plc
  • Illumina, Inc.
  • Johnson and Johnson Services, Inc.
  • QIAGEN
  • Siemens AG
  • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 APAC Virology Market – By Type

1.3.2 APAC Virology Market – By Application

1.3.3 APAC Virology Market – By End User

1.3.4 APAC Virology Market– By Country

2. APAC Virology Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. APAC Virology Market– Market Landscape

4.1 Overview

4.2 APAC PEST Analysis

4.3 Experts Opinion

5. APAC Virology Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Prevalence of Viral Infectious Diseases

5.1.2 Increasing Product Launches

5.2 Market Restraints

5.2.1 Availability of Alternative Products and High Cost of Production of Products

5.3 Market Opportunities

5.3.1 Surging Growth in Several Economies

5.4 Future Trends

5.4.1 Continuous Demand for Cost-Effective Products

5.5 Impact Analysis

6. Virology Market– APAC Analysis

6.1 APAC Virology Market Revenue Forecast and Analysis

7. APAC Virology Market Analysis – By Type

7.1 Overview

7.2 APAC Virology Market Revenue Share, by Type (2021 and 2028)

7.3 Diagnostic Test

7.3.1 Overview

7.3.2 Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Deoxyribonucleic Acid (DNA) Virus Testing

7.3.2.1.1 Overview

7.3.2.1.2 DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2 Ribonucleic Acid (RNA) Virus Testing

7.3.2.2.1 Overview

7.3.2.2.2 RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.3 Others

7.3.2.3.1 Overview

7.3.2.3.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Viral Infection Controlling Techniques

7.4.1 Overview

7.4.2 Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.1 Active Prophylaxis

7.4.2.1.1 Overview

7.4.2.1.2 Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.2 Passive Prophylaxis

7.4.2.2.1 Overview

7.4.2.2.2 Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Antiviral Therapeutics

7.5.1 Overview

7.5.2 Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.1 Virucidal Agents

7.5.2.1.1 Overview

7.5.2.1.2 Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.2 Antiviral Agents

7.5.2.2.1 Overview

7.5.2.2.2 Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.3 Immunomodulators

7.5.2.3.1 Overview

7.5.2.3.2 Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Interferons

7.6.1 Overview

7.6.2 Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8. APAC Virology Market Analysis – By Application

8.1 Overview

8.2 APAC Virology Market, by Application 2021 & 2028 (%)

8.3 Skin and Soft Tissue Infections

8.3.1 Overview

8.3.2 Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Respiratory Tract Infections

8.4.1 Overview

8.4.2 Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.5 GI Tract Infections

8.5.1 Overview

8.5.2 GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Sexually Transmitted Diseases

8.6.1 Overview

8.6.2 Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Urinary Tract Infections

8.7.1 Overview

8.7.2 Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9. APAC Virology Market Analysis – By End User

9.1 Overview

9.2 APAC Virology Market Revenue Share, by End User (2021 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Diagnostic Laboratories

9.4.1 Overview

9.4.2 Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Pharmaceutical and Biotechnological Companies

9.5.1 Overview

9.5.2 Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Research and Academic Institutes

9.6.1 Overview

9.6.2 Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)

10. APAC Virology Market – Country Analysis

10.1.1 Overview

10.1.2 Asia Pacific: Virology Market, by Country, 2021 & 2028 (%)

10.1.2.1 China: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1 China: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2 China: Virology Market, By Type, 2019–2028 (USD Million)

10.1.2.1.2.1 China: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.1.2.2 China: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.1.2.3 China: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.1.3 China: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.1.4 China: Virology Market, by End User, 2019–2028 (USD Million)

10.1.2.2 Japan: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 Japan: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2 Japan: Virology Market, By Type, 2019–2028 (USD Million)

10.1.2.2.2.1 Japan: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.2.2.2 Japan: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.2.2.3 Japan: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.2.3 Japan: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.2.4 Japan: Virology Market, by End User, 2019–2028 (USD Million)

10.1.2.3 India: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1 India: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2 India: Virology Market, By Type, 2019–2028 (USD Million)

10.1.2.3.2.1 India: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.3.2.2 India: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.3.2.3 India: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.3.3 India: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.3.4 India: Virology Market, by End User, 2019–2028 (USD Million)

10.1.2.4 South Korea: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.1 South Korea: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2 South Korea: Virology Market, By Type, 2019–2028 (USD Million)

10.1.2.4.2.1 South Korea: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.4.2.2 South Korea: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.4.2.3 South Korea: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.4.3 South Korea: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.4.4 South Korea: Virology Market, by End User, 2019–2028 (USD Million)

10.1.2.5 Australia: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.1 Australia: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.2 Australia: Virology Market, By Type, 2019–2028 (USD Million)

10.1.2.5.2.1 Australia: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.5.2.2 Australia: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.5.2.3 Australia: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.5.3 Australia: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.5.4 Australia: Virology Market, by End User, 2019–2028 (USD Million)

10.1.2.6 Rest of Asia Pacific: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.1 Rest of Asia Pacific: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.2 Rest of Asia Pacific: Virology Market, By Type, 2019–2028 (USD Million)

10.1.2.6.2.1 Rest of Asia Pacific: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.6.2.2 Rest of Asia Pacific: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.6.2.3 Rest of Asia Pacific: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.6.3 Rest of Asia Pacific: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.6.4 Rest of Asia Pacific: Virology Market, by End User, 2019–2028 (USD Million)

11. Impact of COVID-19 Pandemic on APAC Virology Market

11.1 Overview

12. APAC Virology Market–Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Abbott

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Johnson and Johnson Services, Inc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 F. HOFFMANN-LA ROCHE LTD.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 THERMO FISHER SCIENTIFIC INC.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 QIAGEN

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Illumina, Inc.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Siemens AG

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 GlaxoSmithKline Plc

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 AbbVie Inc.

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Gilead Sciences, Inc.

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. APAC Virology Market Revenue and Forecast to 2028 (US$ Million)

Table 2. China: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 3. China Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 4. China Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 5. China Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 6. China: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 7. China: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 8. Japan: Virology Market, By Type– Revenue and Forecast to 2028 (USD Million)

Table 9. Japan Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 10. Japan Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 11. Japan Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 12. Japan: Virology Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 13. Japan: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 14. India: Virology Market, By Type– Revenue and Forecast to 2028 (USD Million)

Table 15. India Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 16. India Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 17. India Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 18. India: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 19. India: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 20. South Korea: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 21. South Korea Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 22. South Korea Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 23. South Korea Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 24. South Korea: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 25. South Korea: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 26. Australia: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 27. Australia Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 28. Australia Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 29. Australia Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 30. Australia: Virology Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 31. Australia: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 32. Rest of Asia Pacific: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 33. Rest of Asia Pacific Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 34. Rest of Asia Pacific Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 35. Rest of Asia Pacific Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 36. Rest of Asia Pacific: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 37. Rest of Asia Pacific: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 38. Organic Developments Done by Companies

Table 39. Inorganic Developments Done by Companies

Table 40. Glossary of Terms, APAC Virology Market

LIST OF FIGURES

Figure 1. APAC Virology Market Segmentation

Figure 2. APAC Virology Segmentation, By Country

Figure 3. APAC Virology Market Overview

Figure 4. Antiviral Therapeutics Held the Largest Share of the Type Segment in APAC Virology Market

Figure 5. Respiratory Tract Infections Held the Largest Share of the Application Segment in APAC Virology Market

Figure 6. India to Show Significant Growth During Forecast Period

Figure 7. APAC PEST Analysis

Figure 8. APAC Virology Market: Impact Analysis of Drivers and Restraints

Figure 9. APAC Virology Market– Revenue Forecast and Analysis – 2019- 2028

Figure 10. APAC Virology Market Revenue Share, by Type (2021 and 2028)

Figure 11. APAC Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. APAC DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. APAC RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. APAC Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. APAC Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. APAC Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. APAC Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. APAC Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. APAC Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. APAC Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. APAC Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. APAC Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. APAC Virology Market, by Application 2021 & 2028 (%)

Figure 24. APAC Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. APAC Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. APAC GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. APAC Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. APAC Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. APAC Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. APAC Virology Market Revenue Share, by End User (2021 and 2028)

Figure 31. APAC Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. APAC Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. APAC Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. APAC Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Asia Pacific: Virology Market, by Key Country – Revenue (2021) (USD Million)

Figure 36. Asia Pacific: Virology Market, by Country, 2021 & 2028 (%)

Figure 37. China: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 38. Japan: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 39. India: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 40. South Korea: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 41. Australia: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 42. Rest of Asia Pacific: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 43. Impact of COVID-19 Pandemic on Virology Market in APAC Countries

  1. Abbott
  2. AbbVie Inc.
  3. F. Hoffmann-La Roche Ltd.
  4. Gilead Sciences, Inc.
  5. GlaxoSmithKline Plc
  6. Illumina, Inc.
  7. Johnson and Johnson Services, Inc.
  8. QIAGEN
  9. Siemens AG
  10. Thermo Fisher Scientific Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the APAC Virology market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the APAC Virology market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the Virology market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
TIPRE00025735
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.